Related content

VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study

By Zambon Carlo-Federico   Pengo Vittorio   Padrini Roberto   Basso Daniela   Schiavon Stefania   Fogar Paola   Nisi Alessandra   Frigo Anna Chiara   Moz Stefania   Pelloso Michela   Plebani Mario  

Pharmacogenomics, Vol. 12, Iss. 1, 2011-01 ,pp. : 15-25

Future Medicine

Access to resources Recommend Favorite

Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU

By Scott Stuart A   Patel Manishkumar   Martis Suparna   Lubitz Steven A   van der Zee Sarina   Yoo Chang   Edelmann Lisa   Halperin Jonathan L   Desnick Robert J  

Pharmacogenomics, Vol. 13, Iss. 3, 2012-02 ,pp. : 297-307

Future Medicine

Access to resources Recommend Favorite

Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population

By Mitchell Cathrine   Gregersen Nerine   Krause Amanda  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 953-963

Future Medicine

Access to resources Recommend Favorite

Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups

By Scott Stuart A   Khasawneh Rame   Peter Inga   Kornreich Ruth   Desnick Robert J  

Pharmacogenomics, Vol. 11, Iss. 6, 2010-06 ,pp. : 781-791

Future Medicine

Access to resources Recommend Favorite

Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians

By Borgiani Paola   Ciccacci Cinzia   Forte Vittorio   Romano Silvia   Federici Giorgio   Novelli Giuseppe  

Pharmacogenomics, Vol. 8, Iss. 11, 2007-11 ,pp. : 1545-1550

Future Medicine

Access to resources Recommend Favorite